Difficulty: Medium
Average Score: 89%
Practice
A 42-year-old man with ALS presents to his primary care physician for follow-up. He has not had any issues in the last few years and does not need supplemental oxygen. Which of the following agents may be beneficial to delay the need for ventilator support in this patient?
Correct answer
C
Rationale
The correct answer is C) Riluzole. Riluzole is the only drug approved by the FDA for the treatment of amyotrophic lateral sclerosis (ALS). It works by blocking the release of glutamate, which is believed to play a role in the death of motor neurons in ALS. By reducing glutamate levels, riluzole may help slow down the progression of the disease and delay the need for ventilator support.
Option A) Memantine is an NMDA receptor antagonist used in Alzheimer's disease, not ALS. It does not have a proven benefit in delaying the need for ventilator support in ALS.
Option B) Metronidazole is an antibiotic used to treat bacterial and parasitic infections. It has no role in the management of ALS.
Option D) Prednisolone is a corticosteroid used for its anti-inflammatory properties. While it may be used in some autoimmune conditions, it is not indicated for ALS and would not delay the need for ventilator support in this patient.
Educationally, understanding the pharmacological management of ALS is crucial for healthcare providers caring for these patients. Knowing the specific drugs approved for ALS and their mechanisms of action can help in providing optimal care and improving patient outcomes. Riluzole's unique mechanism of action in reducing glutamate levels sets it apart from other drugs and underscores its importance in the treatment of ALS.
Option A) Memantine is an NMDA receptor antagonist used in Alzheimer's disease, not ALS. It does not have a proven benefit in delaying the need for ventilator support in ALS.
Option B) Metronidazole is an antibiotic used to treat bacterial and parasitic infections. It has no role in the management of ALS.
Option D) Prednisolone is a corticosteroid used for its anti-inflammatory properties. While it may be used in some autoimmune conditions, it is not indicated for ALS and would not delay the need for ventilator support in this patient.
Educationally, understanding the pharmacological management of ALS is crucial for healthcare providers caring for these patients. Knowing the specific drugs approved for ALS and their mechanisms of action can help in providing optimal care and improving patient outcomes. Riluzole's unique mechanism of action in reducing glutamate levels sets it apart from other drugs and underscores its importance in the treatment of ALS.